ArticleJournal of medicinal chemistry2020

Preclinical Optimization of gp120 Entry Antagonists as anti-HIV-1 Agents with Improved Cytotoxicity and ADME Properties through Rational Design, Synthesis, and Antiviral Evaluation.

Francesca Curreli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.